An interventional study of Probiotic and Maltodextrin in Obesity, Women, sponsored by Wecare Probiotics Co., Ltd.. Recruiting at 1 site in China. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-23.
Sponsored by Wecare Probiotics Co., Ltd. · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies testing probiotic in Obesity — 9 open to participants now, 12 under way, none of them phase 3. Probiotic · Obesity.
Among the 33 studies testing probiotic in Obesity, this one is the 10th largest by planned enrollment, is one of 10 that started in 2025, is one of 28 with no phase, reaches primary completion later than 3 of the 11 other live ones, and was the 27th registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →9 of the 33 studies testing probiotic in Obesity are open now, in 6 countries. Recruiting first, the newest first:
Chinese Academy of Sciences · Sites in China
Ages 20–50 · Healthy volunteers
Celia Bañuls · Sites in Spain
Ages 18–65
Lallemand Health Solutions · Sites in France
Ages 50–70 · Healthy volunteers
The Archer-Daniels-Midland Company · Sites in Korea, Republic of
Ages 19–75 · Healthy volunteers
University of Ulster · Sites in United Kingdom
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
No approval found in the FDA or EMA files read. How studies give it is on its page →
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 40 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 10 started in 2025.
This study's planned enrollment of 100 is above the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 76 across the 33 interventional studies. Of the 17 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 33 have an industry lead sponsor. The 10 most frequent:
Wecare Probiotics Co., Ltd. is the lead sponsor of 67 studies on the registry; 23 are open to participants now.
Wecare Probiotics Co., Ltd. has 8 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
5 of the studies testing probiotic in Obesity that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07507929Wecare Probiotics Co., Ltd.Probiotic for Weight Management in Overweight and Obese Adults | 2026-12-01 |
| NCT06989177Chinese Academy of SciencesProbiotic Intervention on Body Weight | 2026-12-30 |
| NCT06912100University of ConnecticutL. Acidophilus (Strain TW01) on Gut Health, Body Composition, and Inflammation | 2026-12-31 |
| NCT07505212Prairie View A&M UniversityEffects of Gallotannins on the Gut Microbiome and How it Affects Inflammatory Markers Among Obese Individuals. | 2027-02-14 |
| NCT06901739Celia BañulsTherapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity. | 2027-04-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 33 studies testing probiotic in Obesity, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To evaluate the regulatory effect of Lactobacillus plantans Lp90 formula on visceral fat metabolism and sex hormone balance in obese women.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-
Exclusion Criteria:
Have suffered from hepatitis (, ), or syphilis in the past.
-
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.
Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.
Hepatitis C is a virus that infects the liver. An HCV antibody test can stay positive after an infection has cleared (and is occasionally positive without one); an HCV RNA test shows whether the virus is there now.
After treatment, hepatitis C counts as cured when HCV RNA is still undetectable 12 weeks or more after the treatment ended. Studies often accept people cured this way.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hepatitis B tests
Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.
Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hepatitis C tests
Hepatitis C is a virus that infects the liver. An HCV antibody test can stay positive after an infection has cleared (and is occasionally positive without one); an HCV RNA test shows whether the virus is there now.
After treatment, hepatitis C counts as cured when HCV RNA is still undetectable 12 weeks or more after the treatment ended. Studies often accept people cured this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Take Lactobacillus plantarum Lp90 at 30 billion CFU per day.
Dietary Supplement: Probiotic
Taking maltodextrin 3 g/day.
Dietary Supplement: Maltodextrin
The trial period of this study is 3 months, and each patient will undergo 4 visits (in month 0, month 1, month 2, and month 3).
The trial period of this study is 3 months, and each patient will undergo 4 visits (in month 0, month 1, month 2, and month 3).
The changes of estradiol before and after the intervention
The serum estrogen content of the subjects before and after the intervention was detected by enzyme-linked immunosorbent assay.
Time frame: 0, 1, 2, 3 months
Start is estimated for Jun 2025; primary completion for Sep 2025, 3 months later.
Of 164 industry-sponsored interventional studies with no phase under Obesity, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 27. This study's planned 3 months is below that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Probiotic